» Articles » PMID: 31483823

Honokiol, Magnolol and Its Monoacetyl Derivative Show Strong Anti-fungal Effect on Fusarium Isolates of Clinical Relevance

Overview
Journal PLoS One
Date 2019 Sep 5
PMID 31483823
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The antifungal activity of magnolol and honokiol, two naturally occurring hydroxylated biphenyls, and of their synthetic derivatives was evaluated on a collection of representative isolates of Fusarium oxysporum, F. solani and F. verticillioides of clinical and ecological concern. The tested compounds were proposed as a 'natural' alternative to conventional fungicides, even though a larger range of concentrations (5-400 μg/ml) was applied. The activity of magnolol and honokiol was compared with that of terbinafine (0.1-10 μg/ml), and fluconazole (1-50 μg/ml), two fungicides widely used in treating fungal infections on humans. Magnolol showed similar fungicidal activity compared to fluconazole, whereas honokiol was more effective in inhibiting mycelium growth compared to this fungicide on all tested clinical Fusarium spp. isolates. Compared to terbinafine, honokiol showed similar antifungal activity when tested on clinical F. solani isolates, whereas magnolol was less effective at all selected concentrations (5-400 μg/ml). The different position of the phenol-OH group, as well as its protection, explain different in vitro activities between magnolol, honokiol, and their derivatives. Furthermore, magnolol showed mycelium dry weight reduction at a concentration of 0.5 mM when tested on a set of agricultural isolates of Fusaria, leading to complete inhibition of some of them. Magnolol and honokiol are proposed as efficient and safe candidates for treating clinically relevant Fusaria.

Citing Articles

Identification and Validation of Magnolol Biosynthesis Genes in .

Yang Y, Li Z, Zong H, Liu S, Du Q, Wu H Molecules. 2024; 29(3).

PMID: 38338333 PMC: 10856379. DOI: 10.3390/molecules29030587.


Mechanistic insights of magnolol antimicrobial activity against using untargeted metabolomic analyses.

Qiao H, Tengfei Z, Wenting Z, Qin L, Yunqing G, Xiaoyi C Front Cell Infect Microbiol. 2023; 13:1325347.

PMID: 38152121 PMC: 10751911. DOI: 10.3389/fcimb.2023.1325347.


Identification of a New Causing Sorghum Leaf Spot Disease and Its Management Using Natural Product and Microorganisms.

Wei G, Zhao W, Hu A, Ren M, Huang Y, Xu H Microorganisms. 2023; 11(6).

PMID: 37374932 PMC: 10304900. DOI: 10.3390/microorganisms11061431.


Magnolol, a Neolignan-like Drug, Inhibits Porcine Epidemic Diarrhea Virus Replication in Cultured Cells.

Wang X, Chen B, Yu R, Si F, Xie C, Li Z Pathogens. 2023; 12(2).

PMID: 36839535 PMC: 9965036. DOI: 10.3390/pathogens12020263.


First Report on Causing Anthracnose in Chinese Sorghum and Its Management Using Phytochemicals.

Zhao W, Hu A, Ren M, Wei G, Xu H J Fungi (Basel). 2023; 9(2).

PMID: 36836393 PMC: 9958897. DOI: 10.3390/jof9020279.


References
1.
Hajduk P, Bures M, Praestgaard J, Fesik S . Privileged molecules for protein binding identified from NMR-based screening. J Med Chem. 2000; 43(18):3443-7. DOI: 10.1021/jm000164q. View

2.
Denning D . Echinocandins: a new class of antifungal. J Antimicrob Chemother. 2002; 49(6):889-91. DOI: 10.1093/jac/dkf045. View

3.
Amblard F, Govindarajan B, Lefkove B, Rapp K, Detorio M, Arbiser J . Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol. Bioorg Med Chem Lett. 2007; 17(16):4428-31. PMC: 2001289. DOI: 10.1016/j.bmcl.2007.06.024. View

4.
Nucci M, Anaissie E . Fusarium infections in immunocompromised patients. Clin Microbiol Rev. 2007; 20(4):695-704. PMC: 2176050. DOI: 10.1128/CMR.00014-07. View

5.
Ahearn D, Zhang S, Stulting R, Schwam B, Simmons R, Ward M . Fusarium keratitis and contact lens wear: facts and speculations. Med Mycol. 2008; 46(5):397-410. DOI: 10.1080/13693780801961352. View